NanoCellect Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- NanoCellect Biomedical's estimated annual revenue is currently $4.4M per year.
- NanoCellect Biomedical received $0.2M in venture funding in January 2018.
- NanoCellect Biomedical's estimated revenue per employee is $77,500
- NanoCellect Biomedical's total funding is $47M.
Employee Data
- NanoCellect Biomedical has 57 Employees.
- NanoCellect Biomedical grew their employee count by -22% last year.
NanoCellect Biomedical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is NanoCellect Biomedical?
NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. NanoCellect's game changing technology offers unique solutions to barriers imposed by current state of the art flow cytometers. We use microfluidics with an integrated sorting system that immensely simplifies the process of analyzing and sorting distinct populations of cells from a heterogeneous population.
keywords:Biotechnology,Cleantech,Hardware,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power
$47M
Total Funding
57
Number of Employees
$4.4M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NanoCellect Biomedical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Accounting Manager | Reveal Email/Phone |
2 | VP Commercial | Reveal Email/Phone |
3 | Field Applications Scientist Manager | Reveal Email/Phone |
4 | Sr Product Management | Reveal Email/Phone |
5 | Senior Product Manager | Reveal Email/Phone |
6 | Head Support and Customer Success | Reveal Email/Phone |
7 | Associate Director Systems Engineering | Reveal Email/Phone |
8 | Sr Technical Sales Specialist | Reveal Email/Phone |
9 | Founder, President | Reveal Email/Phone |
10 | Co-Founder, VP Business Development | Reveal Email/Phone |
NanoCellect Biomedical News
... Molecular MD; Molecular Pathology Laboratory Network; Myriad RBM; Namocell; NanoCellect Biomedical; NanoFCM; NeoGenomics Laboratories...
Photo Courtesy of NanoCellect The proceeds from NanoCellect’s $35 million funding rounds will support the development and launch of its second-generation WOLF G2 cell sorting system. NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell so ...
SAN DIEGO, Calif., Sept. 16, 2021 /PRNewswire/ -- NanoCellect Biomedical Inc. ("NanoCellect"), the market-leading provider of microfluidic cell sorting solutions to advance cellular discoveries announced the close of $35M of financing to further accelerate commercial growth plans and new produ ...
SAN DIEGO, May 13, 2021 /PRNewswire/ -- NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect's family of products. The WOLF G2 features simple and sterile ce ...
NanoCellect Biomedical's WOLF Cell Sorter enables users to sort cells with greater confidence that the cells will survive. The Cell Sorter does ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.3M | 57 | 10% | N/A |
#2 | $10.5M | 57 | 2% | N/A |
#3 | $6.9M | 57 | 12% | $4.9M |
#4 | $13.9M | 57 | -2% | N/A |
#5 | $5.2M | 57 | -15% | N/A |
NanoCellect Biomedical Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-11-17 | $0.5M | Undisclosed | Article | |
| 2016-01-26 | $1.8M | Undisclosed | Article | |
| 2017-11-30 | $10.0M | B | Multiple | Article |
| 2018-01-15 | $0.2M | Undisclosed | Highlander Venture Fund | Article |